Spondylitis

Common Name(s)

Spondylitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spondylitis" returned 1236 free, full-text research articles on human participants. First 3 results:

The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
 

Author(s): Marian Tošovský, Petr Bradna, Ctirad Andrýs, Kateřina Andrýsová, Eva Cermáková, Tomáš Soukup

Journal: Acta Medica (Hradec Kralove). 2014 ;57(2):56-61.

 

Ankylosing spondylitis (AS) is an inflammatory rheumatic disease characterized by the development of osteoproductive changes in the spine which could possibly result in ankylosis. Treatment with tumour necrosis factor alpha (TNFα) inhibitors has proved to be an important step forward ...

Last Updated: 26 Sep 2014

Go To URL
Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2).
 

Author(s): T Karaderi, S M Keidel, J J Pointon, L H Appleton, M A Brown, D M Evans, B P Wordsworth

Journal: Ann. Rheum. Dis.. 2014 Nov;73(11):2054-8.

 

ANTXR2 variants have been associated with ankylosing spondylitis (AS) in two previous genome-wide association studies (GWAS) (p∼9×10(-8)). However, a genome-wide significant association (p<5×10(-8)) was not observed. We conducted a more comprehensive analysis of ANTXR2 in an independent ...

Last Updated: 7 Oct 2014

Go To URL
Ankylosing spondylitis and rheumatoid arthritis: serum levels of TNF-α and Its soluble receptors during the course of therapy with etanercept and infliximab.
 

Author(s): Martin Schulz, Helmut Dotzlaw, Gunther Neeck

Journal: Biomed Res Int. 2014 ;2014():675108.

 

The effects of the TNF- α blockers infliximab or etanercept on the levels of TNF- α , TNF-receptor 1 (TNF-R1), and TNF-receptor 2 (TNF-R2), as well as the levels of the inflammation markers CRP and IL-6, were measured in ankylosing spondylitis (AS) and rheumatoid arthritis (RA) ...

Last Updated: 30 Apr 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spondylitis" returned 87 free, full-text review articles on human participants. First 3 results:

Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.
 

Author(s): Fernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, Begoña Ubilla, Beatriz Carnero-López, Ricardo Blanco, Trinitario Pina, Carlos González-Juanatey, Javier Llorca, Miguel A González-Gay

Journal: Biomed Res Int. 2014 ;2014():860651.

 

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease. AS patients also display a high prevalence of features clustered under the name of metabolic syndrome (MeS). Anti-TNF- ...

Last Updated: 23 Apr 2014

Go To URL
Ankylosing spondylitis: an update.
 

Author(s): Vera Golder, Lionel Schachna

Journal: Aust Fam Physician. 2013 Nov;42(11):780-4.

 

Ankylosing spondylitis (AS) affects one in 200 individuals and is usually diagnosed many years after onset of symptoms. Chronic back pain is common and recognition of early disease requires clinical experience and a high index of suspicion. Further, inflammatory markers are not invariably ...

Last Updated: 12 Nov 2013

Go To URL
Variables related to work productivity loss in patients with ankylosing spondylitis.
 

Author(s): Renata Frauendorf, Marcelo de Medeiros Pinheiro, Rozana Mesquita Ciconelli

Journal: Rev Bras Reumatol. ;53(3):303-9.

 

The work productivity loss due to ankylosing spondylitis (AS) has become subject of interest because of its socioeconomic impact. In addition to physical limitations, other variables seem to affect the productivity of those patients, who often withdraw early from the labor force. ...

Last Updated: 20 Sep 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Progression of Spinal Fusion in Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Spondylitis, Ankylosing

 

Last Updated: 11 Nov 2014

Go to URL
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Ankylosing Spondylitis

 

Last Updated: 25 Nov 2014

Go to URL